Ditropan-associated Esotropia - PowerPoint PPT Presentation

1 / 9
About This Presentation
Title:

Ditropan-associated Esotropia

Description:

... lacrimation Ocular side-effects of tolterodine and oxybutynin, a single-blind prospective randomized trial Altan-Yaycioglu et al. Br J Clin Pharmacol 95:5, ... – PowerPoint PPT presentation

Number of Views:29
Avg rating:3.0/5.0
Slides: 10
Provided by: Wong50
Category:

less

Transcript and Presenter's Notes

Title: Ditropan-associated Esotropia


1
Ditropan-associated Esotropia
  • Dr. Elaine Wong
  • Dr. Lionel Kowal
  • Ocular motility clinic, RVEEH
  • CERA, Uni Melb, RVEEH

2
Ditropan-associated ET
  • 5 yo girl
  • PMHx
  • Hypothyroidism on oroxine
  • Enuresis
  • HOPC
  • Recent onset intermittent ET
  • Closing L eye when drawing or reading
  • Recently started on Ditropan (Oxybutynin) for
    enuresis

3
Examination _at_ presentation
  • VAR 6/8 VAL 6/8
  • Near VAR 6/9 VAL 6/8
  • Stereopsis Titmus fly 100
  • CT D) RET 15? N) RET 35?
  • OM normal
  • Polarised 4 dot test R suppression
  • Cycloplegic refraction
  • R 3.25 L 2.75

4
Ditropan-associated ET
  • After cessation of Oxybutynin
  • VAR 6/8 VAL 6/8
  • Near VAR 6/6 VAL6/8
  • CT D) orthophoria
  • N) orthophoria
  • ELAINE CHECK THE DATA ON THIS SLIDE PLS
  • Polarised 4 dot test Fusion
  • Stereopsis Titmus fly 100

5
Discussion - Oxybutynin
  • Muscarinic receptor antagonist often used for
    overactive bladder
  • COMMONLY PRESCRIBED
  • Anticholinergic systemic SE
  • Ocular effects
  • Ciliary ganglion accomodation
  • Pterygopalatine ganglion lacrimation

6
Ocular side-effects of tolterodine and
oxybutynin, a single-blind prospective randomized
trial
  • Altan-Yaycioglu et al. Br J Clin Pharmacol 955,
    588-592
  • 52 patients, 104 eyes
  • Randomised into
  • Tolterodine 2mg bd 28 pts
  • Oxybutynin 5 mg tds 24 pts
  • All examined by ophthalmologists
  • Schirmers
  • Accomodative amplitude
  • Pupillary diameter PD

7
Discussion
  • Tolterodine Oxybutynin
  • Accom amp (DS) 2.06 to 1.65 2.18 to 1.80
  • (p 0.07) (p 0.003)
  • Schirmers (mm) 12.82 to 12.32 12.21 to 14.83
  • (p 0.698) (p 0.342)
  • PD bright (mm) 1.94 to 2.02 2.07 to 2.08
  • (p 0.174) ( p 0.953)

8
Discussion
  • In this case Oxybutynin
  • Impairs accommodation
  • Pre-existing moderate uncorrected
  • To accommodate sufficiently to see, the pt
    converges, and the CA/C ratio then generates
    accommodation
  • hence ESOTROPIA!!!
  • ? Is Tolterodine (Detrusitol) safer

9
Ditropan
  • Frequently prescribed
  • Has never been described as cause of ET!
  • Likely to cause ?accommodation and ? convergence
  • Dit hyperopia likely to cause ET
  • Almost certainly underrecognised
Write a Comment
User Comments (0)
About PowerShow.com